APAC Bladder Disorders Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	161 Pages	Data Bridge Market Research	September, 2022	DAABD17403899

Best Price Guarantee
Price	from $3,500
Length	161 Pages
Publisher	Data Bridge Market Research
Published Date	September, 2022
SKU	DAABD17403899

APAC Bladder Disorders Market - Industry Trends and Forecast to 2029

The Asia-Pacific bladder disorders market is projected to register a substantial CAGR of 13.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation
Asia-Pacific Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippine, Rest of Asia-Pacific) – Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Asia-Pacific bladder disorders market are:
• Growing technological advancement
• Growing geriatric population
• Strategic initiatives adopted by market players
• High prevalence of bladder disorders

Market Players

The major companies which are operating in the Asia-Pacific bladder disorders market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Swati Spentose
• Urovant Sciences, among others.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Asia Pacific Bladder Disorders Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter's Five Forces; 4.3 Asia Pacific Bladder Disorders Market, Pipeline Analysis
5 Asia Pacific Bladder Disorder Market: Regulations: 5.1 The U.S. Regulatory Framework For Bladder Disoreder Medication; 5.2 Europe Regulatory Framework For Bladder Disorder Drugs; 5.3 Japan Regulatory Guidance On Bladder Disorder Drugs
6 Asia Pacific Bladder Disorders Market Overview: 6.1 Drivers; 6.1.1 Strategic Initiatives Adopted By Market Players; 6.1.2 Growing Geriatric Population; 6.1.3 Rising R&D Investments And Launch Of Novel Therapies In Upcoming Years; 6.1.4 Combination Of Different Target Therapies; 6.2 Restraints; 6.2.1 High Cost Associated With Bladder Disorder Diagnostic Treatment; 6.2.2 Products Recalls From Market; 6.3 Opportunities; 6.3.1 Surge In Novel Technological Advancements; 6.3.2 Rising Disease Management Programs; 6.4 Challenges; 6.4.1 Lack Of Awareness About Bladder Disorders Related Problems; 6.4.2 Patent Expiry Of Drugs
7 Asia Pacific Bladder Disorders Market, By Type: 7.1 Overview; 7.2 Overactive Bladder; 7.3 Urinary Incontinence; 7.4 Cystitis; 7.5 Interstitial Cystitis; 7.6 Bladder Cancer; 7.7 Others
8 Asia Pacific Bladder Disorders Market, By Treatment Type: 8.1 Overview; 8.2 Medication; 8.2.1 Tolterodine; 8.2.2 Mirabegron; 8.2.3 Fesoterodine; 8.2.4 Oxybutynin; 8.2.5 Solifenacin; 8.2.6 Darifenacin; 8.2.7 Trospium; 8.2.8 Others; 8.3 Surgery; 8.3.1 Surgery To Increase Bladder Capacity; 8.3.2 Bladder Removal; 8.3.3 Others; 8.4 Others
9 Asia Pacific Bladder Disorders Market, By Distribution Channel: 9.1 Overview; 9.2 Direct; 9.3 Retail
10 Asia Pacific Bladder Disorders Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Clinics; 10.4 Ambulatory Surgical Centers; 10.5 Others
11 Asia Pacific Bladder Disorders Market, By Geography: 11.1 Asia-pacific; 11.1.1 China; 11.1.2 Japan; 11.1.3 India; 11.1.4 Australia; 11.1.5 South Korea; 11.1.6 Thailand; 11.1.7 Singapore; 11.1.8 Indonesia; 11.1.9 Malaysia; 11.1.10 Vietnam; 11.1.11 Philippines; 11.1.12 Rest Of Asia-pacific
12 Asia Pacific Bladder Disorders Market: Company Landscape: 12.1 Company Share Analysis: Asia Pacific
13 Swot Analysis
14 Company Profile: 14.1 Merck And Co. Inc. (2021); 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Astellas Pharma Inc. (2021); 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Bristol-myers Squibb Company (2021); 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation (2021); 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Viatris Inc. (2021); 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development; 14.6 Abbvie (2021); 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Axonics, Inc. (2021); 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development; 14.8 Blue Wind Medical (2021); 14.8.1 Company Snapshot; 14.8.2 Product Portfolio; 14.8.3 Recent Development; 14.9 Coloplast Corp. (2021); 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 14.10 Gaylord Chemical Company, Llc (2021); 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Johnson & Johnson Services, Inc. (2021); 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Kyorin Pharmaceutical Co., Ltd. (A Subsidiary Of Kyorin Holdings, Inc.) (2021); 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Developments; 14.13 Laborie (2021); 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Medtronic (2021); 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Developments; 14.15 Pfizer Inc. (2021); 14.15.1 Company Snapshot; 14.15.2 Revenue Analysis; 14.15.3 Product Portfolio; 14.15.4 Recent Developments; 14.16 Valencia Technologies (2021); 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Sun Phamaceutical Industries Ltd. (2021); 14.17.1 Company Snapshot; 14.17.2 Revenue Analysis; 14.17.3 Product Portfolio; 14.17.4 Recent Development; 14.18 Swati Spentose (2021); 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development; 14.19 Urovant Sciences (2021); 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Zydus Group (2021); 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development
15 Questionnaire
16 Related Reports 161
List Of Tables: Table 1 Asia Pacific Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 2 Asia Pacific Overactive Bladder In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 3 Asia Pacific Urinary Incontinence In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 4 Asia Pacific Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 5 Asia Pacific Interstitial Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 6 Asia Pacific Bladder Cancer In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 7 Asia Pacific Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 8 Asia Pacific Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 9 Asia Pacific Medication In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 10 Asia Pacific Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 11 Asia Pacific Surgery In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 12 Asia Pacific Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 13 Asia Pacific Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 14 Asia Pacific Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 15 Asia Pacific Direct In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 16 Asia Pacific Retail In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 17 Asia Pacific Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 18 Asia Pacific Hospitals In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 19 Asia Pacific Clinics In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 20 Asia Pacific Ambulatory Surgical Centers In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 21 Asia Pacific Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million); Table 22 Asia-pacific Bladder Disorders Market, By Country, 2020-2029 (Usd Million); Table 23 Asia-pacific Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 24 Asia-pacific Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 25 Asia-pacific Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 26 Asia-pacific Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 27 Asia-pacific Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 28 Asia-pacific Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 29 China Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 30 China Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 31 China Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 32 China Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 33 China Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 34 China Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 35 Japan Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 36 Japan Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 37 Japan Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 38 Japan Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 39 Japan Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 40 Japan Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 41 India Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 42 India Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 43 India Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 44 India Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 45 India Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 46 India Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 47 Australia Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 48 Australia Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 49 Australia Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 50 Australia Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 51 Australia Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 52 Australia Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 53 South Korea Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 54 South Korea Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 55 South Korea Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 56 South Korea Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 57 South Korea Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 58 South Korea Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 59 Thailand Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 60 Thailand Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 61 Thailand Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 62 Thailand Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 63 Thailand Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 64 Thailand Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 65 Singapore Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 66 Singapore Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 67 Singapore Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 68 Singapore Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 69 Singapore Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 70 Singapore Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 71 Indonesia Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 72 Indonesia Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 73 Indonesia Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 74 Indonesia. Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 75 Indonesia Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 76 Indonesia Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 77 Malaysia Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 78 Malaysia Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 79 Malaysia Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 80 Malaysia Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 81 Malaysia Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 82 Malaysia Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 83 Vietnam Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 84 Vietnam Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 85 Vietnam Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 86 Vietnam Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 87 Vietnam Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 88 Vietnam Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 89 Philippines Bladder Disorders Market, By Type, 2020-2029 (Usd Million); Table 90 Philippines Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 91 Philippines Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 92 Philippines Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million); Table 93 Philippines Bladder Disorders Market, By End User, 2020-2029 (Usd Million); Table 94 Philippines Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million); Table 95 Rest Of Asia-pacific Bladder Disorders Market, By Type, 2020-2029 (Usd Million) 112
List Of Figures: Figure 1 Asia Pacific Bladder Disorders Market: Segmentation; Figure 2 Asia Pacific Bladder Disorders Market: Data Triangulation; Figure 3 Asia Pacific Bladder Disorders Market: Droc Analysis; Figure 4 Asia Pacific Bladder Disorders Market: Asia Pacific Vs Regional Market Analysis; Figure 5 Asia Pacific Bladder Disorders Market: Company Research Analysis; Figure 6 Asia Pacific Bladder Disorders Market: Interview Demographics; Figure 7 Asia Pacific Bladder Disorders Market: Dbmr Market Position Grid; Figure 8 Asia Pacific Bladder Disorders Market: Market End User Coverage Grid; Figure 9 Asia Pacific Bladder Disorders Market: Vendor Share Analysis; Figure 10 Asia Pacific Bladder Disorders Market: Segmentation; Figure 11 Rising Epidemic And Pandemic Outbreak And Increasing Prevalence Of Bladder Disorders Expected To Drive The Asia Pacific Bladder Disorders Market In The Forecast Period Of 2022 To 2029; Figure 12 Overactive Bladder Segment Is Expected To Account For The Largest Share Of The Asia Pacific Bladder Disorders Market In 2022 & 2029; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Bladder Disorder Market; Figure 14 Asia Pacific Bladder Disorders Market: By Type, 2021; Figure 15 Asia Pacific Bladder Disorders Market: By Type, 2022-2029 (Usd Million); Figure 16 Asia Pacific Bladder Disorders Market: By Type, Cagr (2022-2029); Figure 17 Asia Pacific Bladder Disorders Market: By Type, Lifeline Curve; Figure 18 Asia Pacific Bladder Disorders Market: By Treatment Type, 2021; Figure 19 Asia Pacific Bladder Disorders Market: By Treatment Type, 2022-2029 (Usd Million); Figure 20 Asia Pacific Bladder Disorders Market: By Treatment Type, Cagr (2022-2029); Figure 21 Asia Pacific Bladder Disorders Market: By Treatment Type, Lifeline Curve; Figure 22 Asia Pacific Bladder Disorders Market: By Distribution Channel, 2021; Figure 23 Asia Pacific Bladder Disorders Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 24 Asia Pacific Bladder Disorders Market: By Distribution Channel, Cagr (2022-2029); Figure 25 Asia Pacific Bladder Disorders Market: By Distribution Channel, Lifeline Curve; Figure 26 Asia Pacific Bladder Disorders Market: By End User, 2021; Figure 27 Asia Pacific Bladder Disorders Market: By End User, 2022-2029 (Usd Million); Figure 28 Asia Pacific Bladder Disorders Market: By End User, Cagr (2022-2029); Figure 29 Asia Pacific Bladder Disorders Market: By End User, Lifeline Curve; Figure 30 Asia-pacific Bladder Disorders Market: Snapshot (2021); Figure 31 Asia-pacific Bladder Disorders Market: By Country (2021); Figure 32 Asia-pacific Bladder Disorders Market: By Country (2022 & 2029); Figure 33 Asia-pacific Bladder Disorders Market: By Country (2021 & 2029); Figure 34 Asia-pacific Bladder Disorders Market: By Type (2022-2029); Figure 35 Asia Pacific Bladder Disorders Market: Company Share 2021 (%) 112